Pfizer (NYSE: PFE) director receives deferred phantom stock award

robot
Abstract generation in progress

Pfizer director James Quincey was granted 1,433.062 phantom stock units as deferred board compensation on March 27, 2026, valued at $27.04 per unit. This award increased his total holding to 77,317.538 phantom units, which represent deferred compensation including dividend equivalents. These units will be settled in cash or common stock at his election upon his retirement from the Board.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments